what we do

Commercializing biosimilars based on our long experience, novel technology, and a proven creative regulatory approach.

 Our Vision

To be one of the largest biosimilars products company in the world, focussing on development and regulatory approval within the shortest time possible. 

What We've Achieved

  • Identified 25 biosimilar candidates with least resistance, both legal and financial, to enter the market.
  • Licensed in or developed several products with current market of over $50 Billion.
  • Created development master plans (DMP) for each product including detailed cost and timeline in consultation with FDA.
  • Applied proprietary technology to reduce the development cost by more than 60%.
  • Secured FDA comments on two lead products--ready for IND filing.
  • Identified potential commercial sponsors ranging from establish biotech companies to specialty product distributors.
  • Reduced the traditional cost of development by 60-80%.